Matt Bennett, Managing Director, joined New Mountain in 2016. He focuses on growth transactions across a range of sectors, including medical devices, biopharmaceuticals, manufacturing services in medical devices and biopharmaceuticals, and clinical services. He serves on the Boards of Emmes, Finvi and Profile Products and works closely with additional NMC companies. He previously served on the Boards of Datavant, Personify, Real Chemistry, Covaris, Gelest, Alteon, Sparta Systems, and Cytel.
Mr. Bennett was previously CEO of CIOX Health (now Datavant). Before that, he held multiple executive roles at Ikaria where he was Executive Vice President, Global Medical Operations and Chief Financial Officer among other roles. Prior to joining Ikaria, he was Executive Vice President, Chief Administrative Officer and Chief Business Officer, at VIASYS Healthcare, Inc. (NYSE: VAS), where he was responsible for the company’s growth strategy and mergers and acquisitions. Before VIASYS, he was a transaction leader on mergers and acquisitions, initial public offerings, and commercial transactions in health care at Morgan, Lewis & Bockius LLP, as well as a health care trial attorney at Stradley, Ronon, Stevens & Young.
He holds an AB in Political Science from Princeton University and a JD from Villanova University School of Law.